Intas  Biopharmaceuticals Limited (IBPL, Ahmedabad, India) has acquired the US-based  biotechnology corporation, Biologics Process Development Incorporated (BPD  Inc., Poway, CA). With the acquisition process underway, both companies are  actively pursuing plans to work closely toward fulfillment of common business  objectives in the area of contract research and manufacturing services (CRAMS).  With agreement in the final stages of completion, the financials have been  undisclosed and will be announced at a later stage.

The  development will facilitate and assist Intas Biopharmaceuticals Limited’s foray  in the US market, especially to expand its CRAMS business. Scott M. Brown, PhD,  will continue as president and chief scientific officer of BPD Inc., and Rajeev  Datar, PhD, will be the new chief executive officer of BPD Inc. 

Mergers and Acquisitions

News

Intas Biopharmaceuticals Limited (IBPL, Ahmedabad, India) has acquired the US-based biotechnology corporation, Biologics Process Development Incorporated (BPD Inc., Poway, CA).